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  THE DEVELOPMENT AND VALIDATION 
OF VISIBLE SPECTROPHOTOMETRIC 
METHODS FOR SIMVASTATIN 
DETERMINATION IN PURE AND 
THE TABLET DOSAGE FORMS 
Two simple and sensitive spectrophotometric methods have been developed 
for the determination of simvastatin (SMT) in pure form and in tablets using 
insitu generated bromine, and p-phenylenediamine (PPDA) or o-dianisidine 
(ODA) as reagents. The methods are based on the bromination of SMT by a 
measured excess of in situ bromine in acid medium followed by the determi-
nation of unreacted bromine by reacting with PPDA and measuring the resul-
ting red colour at 510 nm (method A) or reacting with ODA and measuring the 
absorbance at 470 nm (method B). The conditions for the assay have been 
optimized. Beer’s law is obeyed over the concentration ranges 20-120 and 2-
-12 µg/ml for method A and method B, respectively. The calculated molar 
absorbtivities are 2.24×10
3 and 1.91×10
4 dm
3 mol
-1 cm
-1 for the method A and 
the method B, respectively; 0.1868 and 0.0115 µg/cm
2 being the correspond-
ing Sandell sensitivities. The LOD and LOQ for method A are found to be 2.96 
and 8.97 µg/ml, and the respective values for method B are 0.14 and 0.42 
µg/ml. The intra-day and inter-day precision and accuracies were checked. The 
assay precision was less than 5 % CV and the accuracy was 97.38-103.4 %. The 
methods were used for the determination of SMT in tablets. No interference 
from the excipients added to tablets was found. The accuracy and validity of 
the methods were further ascertained by recovery studies via the standard 
addition technique. 
Key words: simvastatin; determination; spectrophotometry; bromate-bro-
mide. 
 
 
Simvastatin (SMT), chemically known as 
(1S,2S,8S,8aR)-1,2,6,8,8a-hexahydro-1-(2-((2R,4R)-
-terahyro-4-hydroxy-6-oxo-2H-pyran-2-yl)-2,6-dime-
thylnapthalen-8-yl 2,2-dimethylbutanoate (Figure 1), 
belongs to the group of cholesterol-lowering lactones 
known as statins which, in 2007, were identified as 
being the most widely prescribed drugs in the world. 
Statins lower cholesterol by inhibiting the synthesis of 
mevalonic acid, which is a key precusor in cholesterol 
synthesis. SMT, a lipid lowering agent that is derived 
synthetically from a fermentation product of Aspergil-
lus terreus has been found to lessen both normal and 
elevated LDL-C concentrations. The drug is officially 
listed in 2004 United States Pharmacopocia and the 
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official method of its determination is high-performan-
ce liquid chromatography [1]. Various other methods 
such as UV-spectrophotometry [2-7], HPLC [7-12], 
HPTLC [13], miscellar eletrokinetic chromatography 
[14] and voltammetry [15] have been reported for the 
assay of SMT in pharmaceuticals. 
 
Figure 1. Structure of simvastatin. 
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methods using bromate-bromide mixture in acid me-
dium as the brominating agent, and p-phenylenedi-
amine (PPDA) and o-dianisidine (ODA) as chromoge-
nic agents. The methods were found to possess the 
adequate sensitivity and seletectivity to determine SMT 
in tablets. 
EXPERIMENTAL 
Apparatus 
All absorbance measurements were made on a 
Systronics model 106 digital spectrophotometer (Ah-
medabad, India) provided with 1-cm matched quartz 
cells. 
Materials and reagents 
Reference standard sample of SMT was 
obtained from Jubiliant Organosis, Nanjangud, Inidia. 
Tablets containing SMT such as simvofix (Bal Pharm, 
India), zosta (USV, India) were purchased from local 
commercial sources. p-Phenylenediamine (Loba Che-
mie, Mumbai, India) solution (1 %) was prepared in 
0.5 M HCl. o-Dianisidine (Loba Chemie, Mumbai, In-
dia) solution (0.1 %) was prepared in 3:2 acetic acid. 
Required volumes of concentrated acid (Merck, 
Mumbai, India) was diluted with water to get 10 M and 
1.0 M H2SO4. Concentrated acetic acid (Merck, 
mumbai, India) was diluted appropriately with water to 
get 3:2 acid. 
Bromate-bromide solution 
A stock standard bromate-bromide solution equi-
valent to 1000 µg/ml KBrO3 was prepared by dissol-
ving accurately weighed 100 mg of pure chemical 
(Sarabai M. Chemicals, Baroda, India) and 1.0 g of 
KBr (s.d. fine-chem ltd, India) in water and diluted to 
the mark in a 100 ml volumetric flask. The stock so-
lution was diluted appropriately with water to get bro-
mate-bromide solutions containing 300 and 50 µg/ml 
KBrO3 for use in method A and method B, respect-
tively. 
Simvastatin solution 
A stock standard solution of SMT equivalent to 
400 µg/ml
 was prepared by dissolving accurately weigh-
ed about 40 mg of pure drug in 3:2 acetic acid and 
diluted to the volume in a 100 ml calibrated flask with 
the same acid. The solution was diluted to get 40 
µg/ml SMT for method B. 
Methods 
Method A 
Different aliquots (0.0, 0.5, 1.0, 1.5, 2.0, 2.5, 3.0 
ml) of 400 µg/ml SMT solution were accurately mea-
sured and transferred into a series of 10 ml volumetric 
flasks and the total volume was brought to 3.0 ml by 
adding 3:2 acetic acid. To each flask 1.0 ml of 1.0 M 
H2SO4 was added, followed by 1.0 ml of bromate-bro-
mide solution (300 µg/ml in KBrO3); the flasks were 
stoppered and set aside for 10 min. Finally, 1.0 ml of 
1.0 % PPDA solution was added, the volume was 
diluted to the mark with water, mixed well and the 
absorbance was measured at 510 nm vs. the blank 
after 5 min. 
Method B 
Varying aliquots (0.0, 0.5, 1.0, 1.5, 2.0, 2.5, and 
3.0) of 40 µg/ml SMT solution were buretted out into a 
set of 10 ml volumetric flaks and the required quantity 
of 3:2 acetic acid was added to bring the total volume 
to 3.0 ml in each flask. To each flask 1.0 ml each of 
10 M H2SO4 and bromate-bromide reagent (50 µg/ml
 
in KBrO3) were added, the latter being added by means 
of a microburette. The flasks were stoppered and set 
aside for 10 min with occasional shaking. Lastly, 1.0 
ml of 0.10 % ODA solution was added to each flask, 
diluted to the mark with 10 M H2SO4, mixed well and 
the absorbance was measured after 5 min at 470 nm 
against the blank. 
In either method, the concentration of the un-
known is read from the calibration graph or computed 
from the regression equation derived using the absor-
bance-concentration data. 
Procedure for commercial tablets 
Twenty tablets were weighed accurately and 
ground into a fine powder. The powder equivalent to 
40 mg of SMT weighed accurately was transferred 
into a 100 ml volumetric flask and 60 ml of 3:2 acetic 
acid was added. The content was shaken for 15-20 
min and diluted to the volume with the same acid, 
mixed well and filtered using a Whatman No. 42 filter 
paper. First, 10 ml portion of filtrate was discarded 
and a suitable aliquot of the subsequent portion was 
subjected to the analysis by method A or by method B 
after the appropriate dilution. 
RESULTS AND DISCUSSION 
A number of reagents are reported to oxidize 
PPDA to a red-coloured product [16] and ODA to an 
orange-red species [17] in acid medium based on 
which the micro level determination of such reagents 
has been accomplished. The work in the authors’ la-
boratory also revealed that bromine brominates SMT 
in acid medium. These analytical aspects have been 
successfully utilized to develop two sensitive methods 
for the determination of SMT. The methods are based K. BASAVAIAH, K. THARPA: THE DEVELOPMENT AND VALIDATION…  CI&CEQ 14 (3) 205−210 (2008) 
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on the bromination of SMT in acid medium by a 
known excess of in situ bromine and the subsequent 
determination of the unreacted bromine by reacting 
with either PPDA or ODA and measuring the absor-
bance either at 510 nm or at 470 nm. The amount of 
bromine reacted corresponds to the amount of SMT 
which formed the basis for the assay of SMT and the 
reaction was found to follow a 3:2 stoichiometry 
(SMT:KBrO3). The possible reaction scheme is given 
in Scheme 1. 
When a fixed concentration of in situ bromine 
was treated with increasing concentrations of SMT, a 
concomitant decrease in the bromine concentration 
occurred which, being reacted with PPDA or ODA, re-
sulted in a corresponding decrease in the absorbance. 
Optimization of the reaction conditions 
Separate preliminary experiments were carried 
out to find the concentrations of KBrO3, in the pre-
sence of large excess of KBr, required to produce a 
convenient maximum absorbance with PPDA and ODA. 
Under the optimum conditions described, they were 
found to be 30 and 5 µg/ml with PPDA and ODA, 
respectively. Hence, 1.0 ml each of 300 and 50 µg/ml 
KBrO3 (+excess of KBr) was used in method A and 
method B, respectively, in a total volume of 10 ml. 
The effects of different medium of acids were 
studied. The reaction between SMT and liberated Br2 
was too slow in HCl medium. Both reaction steps 
were very slow in H3PO4 medium. The reaction bet-
ween SMT and bromine and that between the un-
used/unreacted bromine and PPDA or ODA were 
found to proceed quantitatively in H2SO4 medium. In me-
thod A, the first step of the reaction was quantitative 
with 1.0 ml of 1.0 M H2SO4 in a total volume of 5.0 ml 
in addition of 3.0 ml of 3:2 acetic acid and the same 
quantity of acid was maintained for the second step, 
i.e. the oxidation of PPDA by bromine. However, both 
steps of the method B required a high concentration; 
about 0.50 M in H2SO4 for the first step and an overall 
5.0 M in H2SO4 for the stabilization of the oxidation 
product of ODA. Lower acid concentrations in method 
B yielded a less stable coloured oxidation product. In 
both methods, bromination of SMT was complete in 
10 min and any delay up to 30 min did not affect the 
results whereas the second step was rapid reaching 
the maximum absorbance in 5 min and the colour 
remained stable for the next 40 min in method A and 
25 min in method B. 
The concentration of ODA and PPDA were fixed 
in order to give the minimum blank absorption and the 
covenant maximum absorbance in the presence of 
bromate-bromide mixture. Two blanks were prepared 
for each system. The first blank which consisted of all 
reactants except SMT gave maximum absorbance. 
The absorbance spectrum for both the blanks and pro-
ducts and the tablet excipients are presented (Figure 
2). The second blank was prepared in the absence of 
SMT and bromate-bromide reagent to evaluate the 
contribution of other reactants to the measured absor-
bance. Since the second blank had significant absor-
bance, all absorbance measurements were made 
against the second blank in both methods. 
Method validation 
Linearity 
A linear correlation was found between the ab-
sorbance and the concentration of SMT. Beer’s law 
was obeyed in the inverse manner. The regression 
analysis of Beer’s law data using the method of least 
squares was made to evaluate the slope (b), the in-
tercept (a) and the correlation coefficient (r) for each 
system, and the calculated values are given in Table 1. 
The graphs showed maximum intercept as descrybed 
by the regression equation, y = a + bx, where y is the 
absorbance and x is the concentration in µg/ml. 
 
Scheme 1. Probable reaction scheme. K. BASAVAIAH, K. THARPA: THE DEVELOPMENT AND VALIDATION…  CI&CEQ 14 (3) 205−210 (2008) 
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Fig. 2. Absorption spectra for tablet excipients, both blanks and products. 
 
Table 1. Regression and analytical parameters 
Parameter  Method A  Method B 
λmax / nm  510  470 
Beer’s law limits, µg/ml 20-120  2-12 
Molar absorbtivity, dm
3 mol
-1 cm
-1 2.2×10
3  1.9×10
4 
Sandell sensitivity, µg/cm  0.1868  0.0115 
Limit of detection, µg/ml 2.96  0.14 
Limit of quantification, µg/ml 8.97  0.42 
Regression equation, y* 
Intercept (a) 
Slope (b) 
0.7347 
-0.0058 
0.6373 
-0.0434 
Correlation coefficient (r) -0.9987  -0.9988 
Sa** 0.09980  0.05716 
Sb***  0.00094 0.00540 
*y = a+bx, where y is the absorbance and x the concentration in µg ml
-1; 
**standard deviation of the intercept; ***standard deviation of the slope 
Detection and quantification limits 
The limits of detection (LOD) and quantification 
(LOQ) calculated according to the current ICH guide-
lines [18] are presented in Table 1. The other sensiti-
vity parameters such as molar absorptivity and San-
dell sensitivity are also contained in Table 1. These 
values suggest that method B is nearly 10 times as 
sensitive as method A which is also fairly sensitive. 
Selectivity 
The selectivity may be defined as the ability of 
the method to determine the analyte in the presence 
of matrix. The selectivity was evaluated by preparing 
a synthetic mixture and it was confirmed that the 
change in signal measured (absorbance) was caused 
only by the analyte. A synthetic mixture with the com-
position of: SMT (40 mg), talc (20 mg), starch (30 
mg), lactose (60 mg), gum arabic (20 mg), magne-
sium stearate (10 mg) and sodium alginate (15 mg); 
the extract was prepared according to the procedure 
described for tablets and analysed. Replicate analy-
ses (n = 7) of the extract by the two methods descry-
bed earlier at 80 µg/ml (method A) and 8 µg/ml (me-
thod B) concentration levels indicated that the inactive 
ingredients did not interfere with SMT determination. 
This was supported by the recovery of SMT, in %, 
which was found to be 98.67±1.3 by method A and 
99.12±0.85 by method B. This is amply illustrated in 
the absorption spectra of the reaction products, res-
pective blanks and the tablet excipients (Figure 2). 
Precision 
The precision of the methods was calculated in 
terms of intermediate precision (intra-day and inter- 
-day) [19]. Three different concentration of SMT were 
analyzed in seven replicates during the same day (in-
tra-day precision) and five consecutive days (inter- 
-day precision). The RSD (%) values of intra-day and 
inter-day studies showed that the precision was good 
(Table 2). 
Accuracy 
The accuracy of an analytical method expresses 
the closeness between the reference value and the 
found value [18-20]. The accuracy was evaluated as 
percentage relative error between the measured con-
centrations and taken concentrations for SMT (Bias 
%). The results obtained are compiled in Table 2 and 
show that the accuracy is good for both methods. K. BASAVAIAH, K. THARPA: THE DEVELOPMENT AND VALIDATION…  CI&CEQ 14 (1) 205−210 (2008) 
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Table 2. Intra-day and inter-day precision and accuracy results 
Intra-day
a Inter-day
b 
Method SMT  taken,  µg/ml 
SMT found
c, µg/ml  Precision
d Accuracy
e SMT  found
c, µg/ml  Precision
d Accuracy
e
30 30.36±0.16  1.38  1.2  30.8±0.45  3.24  2.67 
60 59.46±0.25  1.12  -0.59  61.4±0.78  2.86  2.33 
A 
90 89.05±0.55  1.64  -0.05  88.16±1.33  3.37  -2.04 
3 2.97±0.023  2.05  -1.0  3.06±0.037  2.73  -2.00 
6 5.55±0.034  1.64  -0.76  6.09±0.083  3.07  -1.50 
B 
9 9.11±0.033  0.95  1.22  9.28±0.073  1.76  3.11 
an = 7; 
bn = 5; 
cmean±standard error; 
drelative standard deviation, %; 
ebias % : (found − taken/taken)×100 
 
Application to tablets analysis 
The proposed methods were applied to deter-
mine SMT in two brands of tablets with three different 
doses. The results were compared with those of the 
literature method [6] which consisted of the 
measurement of absorbance of the tablet extract at 
240 nm in methanolic medium. Statistical analysis of 
the results using Student’s t-test for accuracy and F-
test for precision revealed no significant difference 
between the proposed methods and the literature 
method at the 95 % confidence level with respect to 
accuracy and precision (Table 3). 
Recovery study 
The accuracy and validity of the proposed me-
thods were further ascertained by performing reco-
very studies. Pre-analyzed tablet powder was spiked 
with pure SMT at three concentration levels (50,100 
and 150 % of that in tablet powder) and the total was 
found by the proposed methods. In all cases, the ad-
ded SMT recovery percentage values ranged bet-
ween 96.58 and 104.3 % with relative standard devi-
ation of < 4 %. The results of this study given in Table 
4 indicated that the recovery was good, and that the 
co formulated substances did not interfere in the 
determination. 
Table 3. The results of the assay of tablets and statistical eva-
luation. Tabulated t-value at the 95 % confidence level is 2.77; 
tabulated F-value at the 95 % confidence level is 6.39 
Found
a (% of nominal amount±SD)  Tablet Nominal 
Literature 
method 
Method A  Method B 
10 101.6±0.64  102.8±0.96 
t = 2.37 
F  = 2.25 
100.2±1.45
t =2.11 
F  = 5.13 
20 99.74±1.06  98.24±1.86 
t =  1.62 
F  = 3.07 
100.4±2.2
t =  0.64 
F  = 4.30 
Simvofix
b 
40 97.36±0.84  96.85±1.33 
t =  0.74 
F  =2.51 
98.23±1.72
t = 1.07 
F  = 4.19 
5 102.3±1.24  100.6±1.85 
t = 1.74 
F  =2.22 
103.6±2.1
t = 1.23 
F  = 2.87 
10 98.76±0.92  100.1±1.56 
t = 1.71 
F  = 2.88 
99.46±1.92
t = 0.78 
F  =4.36 
Zosta
c 
20 103.5±1.04  101.7±1.67 
t =  2.09 
F  =2.58 
102.3±1.48
t =  1.50 
F  = 2.03 
aMean value of five determinations; 
bBal Pharma (Servetus); 
cUSV (Cor-
vette) 
Table 4. The result of the recovery study via the standard addition technique 
Method A  Method B 
Tablet 
studied  SMT in tablet 
µg/ml 
Pure SMT 
added, µg/ml 
Total found 
µg/ml 
Pure SMT recovered
%±SD* 
SMT in tablet
µg/ml 
Pure SMT 
added, µg/ml
Total found 
µg/ml 
Pure SMT recovered
%±SD* 
40.68 20.0  61.54  104.3±2.6  4.09  2.0  6.11  105.4±3.0 
40.68 40.0  81.32  101.6±1.9  4.09  4.0  8.15  103.7±3.5 
Zosta 
20 mg 
40.68 60.0  104.34 106.1±2.8  4.09  6.0  10.06  101.1±2.7     
38.74 20.0 58.0  96.33±3.1  3.93  2.0  5.84  95.69±3.2 
38.74 40.0 78.2  98.56±2.7  3.93  4.0  7.88  98.72±2.9 
Simvofix 
40 mg 
38.74 60.0 97.2  97.42±2.4  3.93  6.0  9.71  96.34±2.4 
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CONCLUSIONS 
Two simple, rapid, fairly accurate and precise 
and reasonably sensitive spectrophotometric me-
thods were developed for the determination of sim-
vastatin in bulk drug and in tablets. The methods rely 
on the use of simple and cheap chemicals and are 
based on well characterized color reactions. Among 
the two methods proposed, the method using PPDA 
has the advantages of employing lower H2SO4 con-
centration, measuring at longer wavelength. Though 
the method using ODA requires higher acid concen-
tration, it offers the advantage in terms of sensitivity. 
The technique employed is inexpensive but was de-
monstrated to provide the sensitivity comparable to 
the expensive technique like HPLC. Thus, the me-
thods can be used for routine analysis laboratories 
and for quality control purposes. 
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